Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by ScienceFirston Aug 31, 2023 3:25pm
309 Views
Post# 35614429

Fair valuation at this stage, with such results

Fair valuation at this stage, with such results

Pre-Breakthrough Therapy discussions already engaged, feedback received and application not turned down, we should already be value valued at around 300M$US (1.40$US (1.80$CAN)), more or less.  


So don't be surprized if we suddenly walk toward such valuation if the volume on the US side keeps hitting 200,000+ for few consecutive days sporadically over the next month.  That will indicate that some were waiting about a signal and that they got it to enter a position.

40 minutes before closing, we have 371,900 shares traded on the US side, with 262,000 on all Canadian exchange (including 109,000 on the TMX), with lots of Anonymous.

Lets see if some deep pockets want to make a ride with us toward a much fairer valuation.

https://www.stockwatch.com/Quote/DetailM.aspx?C:TLT

<< Previous
Bullboard Posts
Next >>